Kyra A. Gelderman

2.8k total citations
57 papers, 2.2k citations indexed

About

Kyra A. Gelderman is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Kyra A. Gelderman has authored 57 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Hematology. Recurrent topics in Kyra A. Gelderman's work include Complement system in diseases (25 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Immunotherapy and Immune Responses (8 papers). Kyra A. Gelderman is often cited by papers focused on Complement system in diseases (25 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Immunotherapy and Immune Responses (8 papers). Kyra A. Gelderman collaborates with scholars based in Netherlands, Sweden and United States. Kyra A. Gelderman's co-authors include Rikard Holmdahl, Malin Hultqvist, Arko Gorter, Peter Olofsson, Cees van Kooten, Jens Holmberg, Lina Olsson, Gordon D. Ross, Stephen Tomlinson and Angela Pizzolla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Kyra A. Gelderman

55 papers receiving 2.2k citations

Peers

Kyra A. Gelderman

IMMUN

MB

RNMI

ONCOL

PHYSI

George D. Kalliolias United States

Florian C. Kurschus Germany

Druie Cavender United States

Erik Michaëlsson Sweden

Takako Hirata Japan

Eleni Douni Greece

Dongyi He China

Gerald Ranges United States

Bruce Jaffee United States

Sanjaya Singh United States

George D. Kalliolias United States

Kyra A. Gelderman

1.1k ×0.8

IMMUN

779 ×1.3

MB

127 ×0.5

RNMI

449 ×1.9

ONCOL

154 ×0.9

PHYSI

Citations per year, relative to Kyra A. Gelderman Kyra A. Gelderman (= 1×) peers George D. Kalliolias

Countries citing papers authored by Kyra A. Gelderman

Since Specialization

Citations

This map shows the geographic impact of Kyra A. Gelderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyra A. Gelderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyra A. Gelderman more than expected).

Fields of papers citing papers by Kyra A. Gelderman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyra A. Gelderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyra A. Gelderman. The network helps show where Kyra A. Gelderman may publish in the future.

Co-authorship network of co-authors of Kyra A. Gelderman

This figure shows the co-authorship network connecting the top 25 collaborators of Kyra A. Gelderman. A scholar is included among the top collaborators of Kyra A. Gelderman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyra A. Gelderman. Kyra A. Gelderman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Zhang, Lu, Matthijs C. Brouwer, Richard B. Pouw, et al.. (2025). Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation. Journal of Autoimmunity. 155. 103444–103444.

2.

Wang, Haiyu, et al.. (2025). Autoantibodies and therapeutic antibodies against complement factor H. Immunology Letters. 274. 107002–107002. 4 indexed citations

3.

Gelderman, Kyra A., Cees van Kooten, Y K Onno Teng, et al.. (2024). Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus. European Journal of Immunology. 54(11). e2450998–e2450998. 1 indexed citations

4.

Borgers, Jessica S.W., Kyra A. Gelderman, Theo Rispens, et al.. (2024). Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma. Journal for ImmunoTherapy of Cancer. 12(6). e009215–e009215. 8 indexed citations

5.

Wang, Haiyu, Fleur S. van de Bovenkamp, Jos Pool, et al.. (2024). Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators. Frontiers in Immunology. 15. 1288597–1288597. 4 indexed citations

6.

Leeuwen, Ester M. van, Anneke J. van der Kooi, Kyra A. Gelderman, et al.. (2023). Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study. Journal of Autoimmunity. 139. 103081–103081. 2 indexed citations

7.

Baas, Inge O., Claudia C. Folman, Kyra A. Gelderman, et al.. (2023). C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia. Blood Advances. 7(13). 3128–3139. 7 indexed citations

8.

Bovenkamp, Fleur S. van de, Jos Pool, Cynthia S. M. Kramer, et al.. (2023). Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation. Proceedings of the National Academy of Sciences. 120(50). e2310666120–e2310666120. 9 indexed citations

9.

Bovenkamp, Fleur S. van de, et al.. (2021). Circulating C1q levels in health and disease, more than just a biomarker. Molecular Immunology. 140. 206–216. 29 indexed citations

10.

Jacobs, Joannes F.M., et al.. (2018). Analytical validation of the Hevylite assays for M-protein quantification. Clinical Chemistry and Laboratory Medicine (CCLM). 56(7). 1169–1175. 5 indexed citations

11.

Beek, Anna E. van, Simone Kruithof, Ed Nieuwenhuys, et al.. (2018). Reference Intervals of Factor H and Factor H-Related Proteins in Healthy Children. Frontiers in Immunology. 9. 1727–1727. 15 indexed citations

12.

Bakker, Sjoerd F., Adriaan A. van Bodegraven, Ingrid M. W. van Hoogstraten, et al.. (2014). Increased IgA Glycoprotein-2 Specic Antibody Titres in Refractory Celiac Disease. Journal of Gastrointestinal and Liver Diseases. 23(2). 127–133. 18 indexed citations

13.

Kraaij, Marina D., Sandra W. van der Kooij, Marlies E. J. Reinders, et al.. (2011). Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Molecular Immunology. 49(3). 549–557. 57 indexed citations

14.

Kooten, Cees van & Kyra A. Gelderman. (2010). In Vitro-Generated DC with Tolerogenic Functions: Perspectives for In Vivo Cellular Therapy. Methods in molecular biology. 677. 149–159. 5 indexed citations

15.

Gelderman, Kyra A., Malin Hultqvist, Patrick Merky, et al.. (2009). Ncf1-Associated Reduced Oxidative Burst Promotes IL-33R+ T Cell-Mediated Adjuvant-Free Arthritis in Mice. The Journal of Immunology. 183(2). 874–881. 27 indexed citations

16.

Gelderman, Kyra A., Malin Hultqvist, Angela Pizzolla, et al.. (2007). Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. Journal of Clinical Investigation. 117(10). 3020–3028. 199 indexed citations

17.

Gelderman, Kyra A., Suzanne Lam, & Arko Gorter. (2005). Inhibiting complement regulators in cancer immunotherapy with bispecific mAbs. Expert Opinion on Biological Therapy. 5(12). 1593–1601. 15 indexed citations

18.

Sier, Cornelis F.M., Kyra A. Gelderman, Frans A. Prins, & Arko Gorter. (2004). Beta‐glucan enhanced killing of renal cell carcinoma micrometastases by monoclonal antibody G250 directed complement activation. International Journal of Cancer. 109(6). 900–908. 37 indexed citations

19.

Gelderman, Kyra A., et al.. (2002). Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma. European Journal of Immunology. 32(1). 128–128. 1 indexed citations

20.

Gelderman, Kyra A., et al.. (2002). Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma. European Journal of Immunology. 32(1). 128–135. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact